A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy

NCT00833560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Cyclophosphamide
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Janssen-Cilag G.m.b.H